Paper Review Records
全部论文审稿周期
30 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
190
天
Unified Implementation and Comparison of Bayesian Shrinkage Methods for Treatment Effect Estimation in Subgroups
作者
Marcel Wolbers; Miriam Pedrera Gómez; Alex Ocampo; Isaac Gravestock展开收起
作者单位
1. Clinical Statistics and Analytics, Bayer BCC AG Basel Switzerland; 2. Indivi AG Basel Switzerland; 3. Data Science and Analytics, Roche Basel Switzerland展开收起
245
天
Confidence Intervals for the MADET Index and Its Corresponding Classification Thresholds Using Generalized Pivotal Quantities
作者
Fernando J. Nhampossa; Elisa M. Molanes‐López; Emilio Letón展开收起
作者单位
1. Department of Statistics and Operations Research Universidad Complutense de Madrid (UCM) Madrid Spain; 2. Department of Artificial Intelligence Universidad Nacional de Educación a Distancia (UNED) Madrid Spain展开收起
327
天
Joint Model for Assessing the Effect of Frailty and Longitudinal Measures in Time‐To‐Event Outcome
作者
Anand Hari; Divya Dennis; Jagathnath Krishna Kumara Pillai Mohanan Nair; Aleyamma Mathew展开收起
作者单位
1. Manipal Academy of Higher Education Manipal Karnataka India; 2. Division of Cancer Epidemiology and Biostatistics Regional Cancer Centre Thiruvananthapuram Kerala India展开收起
380
天
Variable Selection for the Propensity Score Model: Beyond Main Effects and Linear Relations
作者
Peter C. Austin; Guy Cafri展开收起
作者单位
1. ICES Toronto Ontario Canada; 2. Institute of Health Policy, Management and Evaluation, University of Toronto Toronto Ontario Canada; 3. Sunnybrook Research Institute Toronto Ontario Canada; 4. Medical Device Epidemiology and Real‐World Data Sciences, Global Epidemiology, Office of the Chief Medical Officer, Johnson & Johnson New Brunswick New Jersey USA展开收起
259
天
The Impact of Enrollment Strategies on the Performance of Time‐To‐Event Dose‐Escalation Designs for Phase I Drug Combination Oncology Trials
作者
Xiaowen Tian; Michael Sweeting; Kristine Broglio展开收起
作者单位
1. Oncology Biometrics, Oncology R&D AstraZeneca Gaithersburg Maryland USA; 2. Oncology Biometrics, Oncology R&D AstraZeneca Cambridge UK展开收起
247
天
Hierarchical Composite Endpoints for Dose Optimization in Early Phase Oncology Trials
作者
Yuxiang Wu; Xiaohan Guo; Ray Li; Christophe Le Corre展开收起
作者单位
1. Department of Biostatistics and Bioinformatics Emory University Atlanta Georgia USA; 2. Oncology Biometrics Pfizer New York New York USA展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
